Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 186

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 186
---
, including the shareholders listed below, will have the same voting rights attached to their Ordinary
Shares, and neither our principal shareholders nor our directors and executive officers will have different or special voting rights
with respect to their Ordinary Shares. See “Description of Share Capital—Voting Rights.” A description of any material
relationship that our principal shareholders have had with us or any of our predecessors or affiliates within the past three years is
included under “Certain Relationships and Related Party Transactions.”

Unless otherwise noted below,
the address of each shareholder, director and executive officer is c/o Regentis Biomaterials Ltd., 60 Medinat Hayehudim Street, Herzliya
4676652, Israel.

|                                                             |     | Ordinary     
 Shares       |         |     | Percentage of      
 Ordinary Shares    
 beneficially owned |      |   |     |          |     |   |
| Name of beneficial owner                                    |     | beneficially 
 owned        |         |     | Before             
 offering           |      |   |     | After    
 offering |     |   |
| 5% or Greater Shareholders                                  |     |              |         |     |                    |      |   |     |          |     |   |
| HaisThera Scientific Fund I, L.P.(1)                        |     |              | 246,643 |     |                    | 15.7 | % |     |          |     | % |
| Ocorian Fund Management S.à r.l (2)                         |     |              | 131,766 |     |                    |  8.3 | % |     |          |     | % |
| SCP Vitalife Partners II, L.P. (3)                          |     |              | 119,872 |     |                    |  7.6 | % |     |          |     | % |
| Medica III Investments (International) LP (4)               |     |              | 116,378 |     |                    |  7.3 | % |     |          |     | % |
| DSM Venturing B.V.(5)                                       |     |              | 104,408 |     |                    |  6.6 | % |     |          |     | % |
| Directors and Executive Officers                            |     |              |         |     |                    |      |   |     |          |     |   |
| Dr. Ehud Geller (6)                                         |     |              | 344